Meeting
2020 Genitourinary Cancers Symposium
Association of serum iron and response to immune checkpoint inhibitors (ICIs) in metastatic clear cell renal cell carcinoma (mccRCC).
Authors
Nityam Rathi
University of Utah Huntsman Cancer Institute, Salt Lake City, UT
Nityam Rathi , David D. Stenehjem , Neeraj Agarwal , Andrew W Hahn , Deepika Sirohi , Prayushi Sharma , Mei Yee Koh , Benjamin Louis Maughan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 723)
Abstract #
723
Poster Bd #
H21
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immunotherapy: A systematic review and meta-analysis.
First Author: Fengnian Zhao
Poster
2021 ASCO Annual Meeting
Risk of immunosuppression and hospitalization after checkpoint inhibitor therapy in patients with cancer and radiation therapy.
First Author: Kate E Lee
Poster
2019 ASCO Annual Meeting
Frameshift mutations (Fsindel) complement tumor mutation burden (TMB) in predicting survival after immune checkpoint inhibitors (ICI) in a pancancer analysis.
First Author: Vaia Florou
Poster
2019 Genitourinary Cancers Symposium
Effect of immunotherapy (IO) on primary renal tumor in metastatic renal cell cancer (mRCC).
First Author: Antoine Jamet